Incyte Corporation Q2 2016 Financial Update and Pipeline

Q2 2016 financial and corporate update presentation from Incyte Corporation covering financial guidance, Jakafi sales growth, baricitinib partnership developments with Lilly, and clinical pipeline progress. The presentation includes updates on multiple drug candidates across JAK inhibitors, IDO1 inhibitors, and immuno-oncology programs.